Efficacy and safety of Didanosine (ddI) and tenofovir (TDF) combination as NRTI backbone of highly active antiretroviral treatment (HAART). (24 wk preliminary results from recover study).

1. Galindo, MJ
2. Lopez-Aldeguer, J
3. Salavert, M
4. Estrada, V
5. Cordero, M
6. de Quiros, JCLB
7. Dronda, F
8. Orihuela, F
9. Garcia, RR
10. Chocarro, A
11. Ferrer, VF
12. Vilaro, J
13. Lletget, CC
14. Alvarez, ML
15. Moreno, S